Migraine Clinical Trials

Migraine is a prevalent neurological disorder characterized by recurrent, debilitating headaches that can significantly impact a person's quality of life.

In the realm of migraine management, the array of FDA-approved drugs highlights a timeline of therapeutic evolution and innovation.

To enhance patient outcomes in migraine clinical trials, it is necessary to focus not only on the physiological aspects of migraine relief but also on overall improvements in the quality of life. Endpoints must therefore be relevant to daily living and long-term health.


Migraines affect

1B

people worldwide. It is the 3rd most prevalent illness

 

Migraines are more common in women, with around

18%

of women experiencing migraines

 

There is a genetic predisposition to migraines. Around

90%

of migraine sufferers have a family history of the condition

 

Our clinical team has over

120

years of combined clinical trial experience

 

Download Our Paper

Fill out this form to download our white paper on how to overcome the biggest obstacles in conducting a migraine clinical trial.

iNGENū CRO - Migraine

 

In light of the significant impact migraines have on individuals and society as a whole, continued research and awareness efforts are crucial to improve diagnosis, treatment, and ultimately, the quality of life for those living with this debilitating condition.

The development of clinical trial protocols that meet FDA approval standards is crucial for the success of new migraine treatments.